Pharmaceutical Desiccant Market Information Report, By Type (Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves and Others), By End-Use (Tablets, API’s, Capsules, Diagnostic Kit and Nutraceutical Product Packaging), and By Region - Forecast To 2028
ID: MRFR/CnM/2838-CR | August 2017 | Region: Global | 185 pages
Pharmaceutical Desiccant Market Overview:
The Pharmaceutical Desiccant Market is expected to flourish at a 4.71% CAGR by the end of the forecast period of 2021-2028. The expected market valuation stands to USD 195.89 million by the end of the forecast year of 2028.
Desiccants can be categorized as the materials that help in the absorption of moisture, and introduce the desired level of dryness in the area surrounding the substances. These are both soluble and insoluble in nature. These extend a helping hand in eliminating the excess amount of humidity and have gradually found a way to the Pharmaceutical industry. The global Pharmaceutical Desiccant market is now growing rapidly owing to a large-scale use for the maintenance of quality and strength.
Also, it helps in trusting the purity related to the medical drugs for, quite a long time now. Some of the most commonly used Pharmaceutical desiccants are activated alumina, molecular sieves, as well as, silica gels. These are stipulating a high degree of demand.
COVID 19 Analysis
Under the comprehensive growth of the global pandemic of a novel coronavirus, the pharmaceutical industry has experienced an alarming slow-down of growth. The pharmaceutical desiccant market are experiencing an economic slowdown due to the marketing sufferings in many geographical regions across the world. The pharmaceutical desiccant market growth is sensitive to the economic growth of the country it belongs to. After the spread of the coronavirus on the global level, there has been the new entry of medications in the market which is further increasing the slowdown.
Also, there is a change in priorities of the pharma companies .. however, if the historic trends are to be considered, the pharmaceutical desiccant market share does not always follow the trend. The government is investing in the development of evidence-centered therapies along with the product launching to the portfolio of products offered by the market on a global level.
Competitive Landscape
The Pharmaceutical Desiccant Industry is dependent on the functioning and performance of the key market players like:
- Multisorb Technologies (U.S.)
- Capitol Scientific, Inc (U.S.)
- Desican Inc (U.S.)
- I. du Pont de Nemours and Company (U.S.)
- CSP Technologies, Inc (U.S.)
- Oker-Chemie GmbH (Germany)
- R. Grace & Co (U.S.)
- Desiccare, Inc (U.S.),
- Sanner GmbH (Germany)
- Clariant Global (Switzerland)
Market Dynamics
Drivers
There is a tremendous increase in the aging population, widening growth of the pharmaceutical industry trends, along government interference and initiatives. This is going to ensure a great quality of the medical drugs acting as a major driver for the growth of the global pharmaceutical desiccant market.
Challenges
Varying temperatures, as well as, the stringent regulations from the side of the government authorities that are likely to hamper the market’s growth. Also, the widening demand of the aging population has increased expectations concerning the cost and market-based prices of the products.
Value Chain Analysis
The product type market segment of the pharmaceutical desiccant market includes various products that help in meeting the customer expectations by eliminating moisture and maintaining the levels of purity. Also, these products act as dehydrating agents for both industrial gases, as well as, liquids. Also, the clay beads help in engrossing moisture and keeping the food fresh for a longer time period. Also, the natural clays let the desiccants be used for one more time. All these factors are adding to the boost in the supply-chain mechanism for the end-users of the market.
Segment Overview
The pharmaceutical desiccant industry consists of two market segments namely - type and the end-user.
Type:
The pharmaceutical desiccant market segment of type includes activated alumina, molecular sieves, carbon clay desiccants, as well as, silica gel. In the historic forecast year of 2015, silica gel had the largest market share that summed up to 40%, and had a market valuation of USD 47.2 million. Silica gel is basically non-toxic, and non-flammable. Also, it is safe to be used in the protection of food items and medicines, along with sensitive materials. It is porous in nature and has the capability of absorbing moisture levels. The use of activated alumina extends to the removal of moisture, purification works, and other related treatments.
End-uses
The pharmaceutical desiccant includes the end-uses market segment. This segment deals in tablets and capsules, APIs, nutraceutical product packaging, as well as, diagnostic kits. During the spread of COVID 19, the diagnostic kits were made available to various hospitals, and testing centers. In the historic forecast year of 2015, tablets had the largest market share that accounted for 22% and the market valuation was USD 208.2 million. A similar growth by tablets is expected by the future forecast of 2027 accounting for a 4.16% CAGR.
Regional Analysis of the Pharmaceutical Desiccant Market
The global pharmaceutical desiccant market share is expected to rise at a 4.71% CAGR by the end of the forecast period of 2027, with the APAC region experiencing the fastest growth, on the global level. The expected CAGR is 4.87% owing to the increasing share in the manufacturing activities, and increase in the population of people demanding pharmaceutical desiccants. However, the largest market share on the global level is expected to be enjoyed by the North American regions inclusive of the USA, as well as, Canada. The North American region is expected to grow at a steady rate in the upcoming years with a 4,37% CAGR, and till the end of the forecast year in 2027. The USA, is a major contributor to this market share, because of the growing level of shale gas extraction.
The Gulf of Mexico is increasing its levels of oil production for meeting the need of mass demand and is subsequently taking responsibility for the downstream application markets. This is also going to help the pharmaceutical desiccant market share propel nicely in the geographical locations of Latin America, the Middle East, as well as, Africa.
The key players that are indulged in the manufacturing of tablets are expected to perform well by the end of the forecast period. Also, the manufacturers of silica gel types are expected to have the fastest-growing market and production levels by the end of the global forecast to 2027.
Recent developments
- I. du Pont de Nemours and Company is an MNC that has its headquarters in Wilmington, Delaware. This company offers a variety of products and services in a variety of markets inclusive of nutrition and agriculture, safety, electronics and communication, as well as, protection. Owing to the market widening, and provision of services, the market is expected to experience streamlined growth.
- The company’s operations are expanding to locations like Latin America, Europe, Asian-Pacific regions, as well as, North America. The market holds a considerable market valuation by the end of the forecast year of 2027.
- This company also announced its merger with another company called The Dow Company. The name of the new entity is DowDuPont and extends its work in the production of specialty products, material sciences, as well as, the field of agriculture.
- The healthcare sector is exposed to successful marketing strategies, as well as, the implemented strategies for growth. The adoption of commercialization models as the ways of marketing is acting as a major driving force for the key players located in the European countries.
- July 2019 - Clariant, a leading specialty chemicals company, announced the sale of its Healthcare Packaging business to an Arsenal Capital Partners affiliate. The healthcare packaging unit of the firm produces a wide range of products such as anisters and packets, integrated desiccant systems and plastic bottles which are designed to provide protection from oxygen and moisture.
Pharmaceutical Desiccant Market Report Overview
The global pharmaceutical desiccant market research report carries an extensive analysis of the market and its segments to predict the growth rate of the market, as well as, the market valuation. Also, the report considers the quantitative aspects by the key players in the pharmaceutical desiccant market that are expanded to various geographical locations. The market figures have a concern with the historic, present, as well as, future market trends.
These figures help to project the market size, the volume of production, as well as the values and estimations. The technological requirements, economical advancements, as well as, government regulations have an impact on the market dynamics, which are well discussed, and mentioned, as well. There is a broad study conducted for understanding the impact of COVID 19 on the global market.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2028: USD 195.89 million |
| CAGR | 4.71% (2021-2028) |
| Base Year | 2020 |
| Forecast Period | 2021-2028 |
| Historical Data | 2019 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | type and the end-user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | E. I. du Pont de Nemours and Company (U.S.), Multisorb Technologies (U.S.), Sanner GmbH (Germany), CSP Technologies, Inc (U.S.), Capitol Scientific, Inc (U.S.), Desiccare, Inc (U.S.), W. R. Grace & Co (U.S.), Desican Inc (U.S.), Clariant Global (Switzerland), and Oker-Chemie GmbH (Germany) |
| Key Market Opportunities | Growing rapidly owing to a large-scale use for the maintenance of quality and strength. |
| Key Market Drivers | This is going to ensure a great quality of the medical drugs acting as a major driver |
Frequently Asked Questions (FAQ) :
The global pharmaceutical desiccant market is expected to reach USD 191.3 MN by 2027, registering over 4.71% CAGR during the forecast period (2021-2028).
North America accounts for the largest share in the global pharmaceutical desiccant market. The region is anticipated to retain its dominance throughout the assessment period (2021-2028).
High adoption of desiccants in the pharmaceutical and chemical sectors.
Multisorb Technologies (US), E. I. du Pont de Nemours and Company (US), Sanner GmbH (Germany), Capitol Scientific, Inc. (US), CSP Technologies, Inc. (US), Desiccare, Inc. (US), Desican Inc. ((US), W. R. Grace & Co (US), Clariant Global (Switzerland), and Oker-Chemie GmbH (Germany) are some of the players leading the global pharmaceutical desiccant market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global pharmaceutical desiccant market adopt to gain a larger competitive advantage.
1 Introduction
1.1 Definition 11
1.2 Scope Of The Study 11
1.3 Assumptions 11
1.4 Market Structure 12
2 Research Methodology
2.1 Research Process 13
2.2 Primary Research 14
2.3 Secondary Research 14
2.4 Market Size Estimation 14
2.1 Forecast Model 16
3 Market Dynamics
3.1 Drivers 17
3.1.1 Growing Pharmaceutical Industry 17
3.1.2 Increase In Ageing Population 18
3.1.3 Government Initiative For Pharmaceutical Industry 19
3.2 Restraints 19
3.2.1 Stringent Regulations 19
3.2.2 Temperature Fluctuation 19
3.3 Opportunities 19
3.3.1 Scope In The Developing Nation 19
3.3.2 Establish Partnership 20
3.4 Challenges 20
3.4.1 Market Access Barriers 20
3.4.2 Rising Customer Expectations 20
4 Market Factor Analysis
4.1 Supply Chain Analysis 21
4.2 Porter's Five Forces Analysis 22
4.2.1 Threat Of New Entrants 22
4.2.2 Bargaining Power Of Suppliers 22
4.2.3 Bargaining Power Of Buyers 23
4.2.4 Threat Of Substitutes 23
4.2.5 Rivalry 23
5 Global Pharmaceutical Desiccant Market, By Type
5.1 Introduction 25
5.1.1 Silica Gel 27
5.1.2 Activated 27
5.1.3 Carbonclay Desiccant 27
5.1.4 Molecular Sieves 27
6 Global Pharmaceutical Desiccant Market, By End Use
6.1 Introduction 29
6.1.1 Tablets 31
6.1.2 API’s 31
6.1.3 Capsules 31
6.1.4 Nutraceutical Product Packaging 31
7 Pharmaceutical Desiccant Market, By Region
7.1 Introduction 33
7.2 North America 34
7.2.1 U.S. 37
7.2.2 Canada 38
7.3 Europe 39
7.3.1 Germany 42
7.3.2 U.K. 43
7.3.3 France 44
7.3.4 Spain 45
7.3.5 Italy 46
7.3.6 Rest Of Europe 47
7.4 Asia-Pacific 48
7.4.1 China 51
7.4.2 Japan 52
7.4.3 India 53
7.4.4 Rest Of APAC 54
7.5 Rest Of The World 55
8 Competitive Scenario
8.1 Competitive Landscape 58
8.1.1 New Product Development 59
8.1.2 Expansion 59
8.1.3 Mergers And Acquisitions 60
8.1.4 Partnerships And Collaborations 60
9 Company Profiles
9.1 E. I. Du Pont De Nemours And Company 61
9.1.1 Company Overview 61
9.1.2 Financial Overview 61
9.1.3 Product/Service Offering 62
9.1.4 Strategy 62
9.1.5 SWOT Analysis 63
9.2 Multisorb Technologies 64
9.2.1 Financial Overview 64
9.2.2 Product/Service Offering 64
9.2.3 Strategy 65
9.2.4 SWOT Analysis 65
9.3 Sanner GmbH 66
9.3.1 Financial Overview 66
9.3.2 Product/Service Offering 66
9.3.3 Strategy 66
9.3.4 SWOT Analysis 67
9.4 Clariant Global 68
9.4.1 Company Overview 68
9.4.2 Financial Overview 68
9.4.3 Product/Service Offering 69
9.4.4 Strategy 69
9.4.5 Key Developments 70
9.4.6 SWOT Analysis 70
9.5 CSP Technologies, Inc. 71
9.5.1 Company Overview 71
9.5.2 Financial Overview 71
9.5.3 Product/Service Offering 72
9.5.4 Strategy 72
9.5.5 Key Development 72
9.5.6 SWOT Analysis 73
9.6 Capitol Scientific, Inc. 74
9.6.1 Company Overview 74
9.6.2 Financial Overview 74
9.6.3 Product/Service Offering 74
9.7 Desiccare, Inc. 75
9.7.1 Company Overview 75
9.7.2 Financial Overview 75
9.7.3 Product/Service Offering 75
9.8 W. R. Grace & Co 76
9.8.1 Company Overview 76
9.8.2 Financial Overview 76
9.8.3 Product/Service Offering 77
9.8.4 Key Developments 78
9.9 Desican Inc. 79
9.9.1 Company Overview 79
9.9.2 Financial Overview 79
9.9.3 Product/Service Offering 79
9.10 Oker-Chemie GmbH 80
9.10.1 Financial Overview 80
9.10.2 Product/Business Segment Overview 80
10 List of Tables
TABLE 1 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 26
TABLE 2 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 30
TABLE 3 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY REGION, 2020-2027 (USD MILLION) 33
TABLE 4 NORTH AMERICA: PHARMACEUTICAL DESICCANT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 35
TABLE 5 NORTH AMERICA: PHARMACEUTICAL DESICCANTMARKET SIZE, BY TYPE, 2020-2027 (USD MILLION) 36
TABLE 6 NORTH AMERICA: PHARMACEUTICAL DESICCANTMARKET SIZE, BY END USE, 2020-2027 (USD MILLION) 37
TABLE 7 U.S.: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 37
TABLE 8 U.S.: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 38
TABLE 9 CANADA: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 38
TABLE 10 CANADA: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 39
TABLE 11 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 40
TABLE 12 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 41
TABLE 13 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 42
TABLE 14 GERMANY: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 42
TABLE 15 GERMANY: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 43
TABLE 16 U.K.: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 43
TABLE 17 U.K.: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 44
TABLE 18 FRANCE: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 44
TABLE 19 FRANCE: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 45
TABLE 20 SPAIN: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 45
TABLE 21 SPAIN: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 46
TABLE 22 ITALY: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 46
TABLE 23 ITALY: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 47
TABLE 24 REST OF EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 47
TABLE 25 REST OF EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 48
TABLE 26 APAC PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 49
TABLE 27 APAC PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 50
TABLE 28 APAC PHARMACEUTICAL DESICCANT MARKET, BY END-USE, 2020-2027 (USD MILLION) 50
TABLE 29 CHINA PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 51
TABLE 30 CHINA PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2020-2027 (USD MILLION) 51
TABLE 31 JAPAN PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 52
TABLE 32 JAPAN PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2020-2027 (USD MILLION) 52
TABLE 33 INDIA PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 53
TABLE 34 INDIA PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2020-2027 (USD MILLION) 53
TABLE 35 REST OF APAC PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 54
TABLE 36 REST OF APAC PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2020-2027 (USD MILLION) 54
TABLE 37 ROW PHARMACEUTICAL DESICCANTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 55
TABLE 38 ROW PHARMACEUTICAL DESICCANTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 56
TABLE 39 ROW PHARMACEUTICAL DESICCANTS MARKET, BY END-USE, 2020-2027 (USD MILLION) 57
11 List of Figures
FIGURE 1 RESEARCH PROCESS OF MRFR 13
FIGURE 2 TOP DOWN & BOTTOM UP APPROACH 15
FIGURE 3 DRIVERS & RESTRAINTS IMPACT ANALYSIS OF GLOBAL PHARMACEUTICAL DESICCANT MARKET 17
FIGURE 4 PHARMACEUTICAL PER CAPITA SENDING 2016 (USD MILLION) 18
FIGURE 5 POPULATION AGES 65 AND ABOVE, 2011-2020 (% OF TOTAL) 18
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF GLOBAL PHARMACEUTICAL DESICCANTS MARKET 22
FIGURE 7 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020 (IN %) 25
FIGURE 8 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 26
FIGURE 9 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020 (%) 29
FIGURE 10 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 30
FIGURE 11 GLOBAL PHARMACEUTICAL DESICCANT MARKET, BY REGION, 2020-2027 (USD MILLION) 33
FIGURE 12 GLOBAL: PHARMACEUTICAL DESICCANT MARKET, BY REGION, 2020 (% SHARE) 34
FIGURE 13 NORTH AMERICA: PHARMACEUTICAL DESICCANT MARKET SHARE, BY COUNTRY, 2020 (% SHARE) 34
FIGURE 14 NORTH AMERICA: PHARMACEUTICAL DESICCANT MARKET SIZE, BY TYPE, 2020-2027 (USD MILLION) 35
FIGURE 15 NORTH AMERICA: PHARMACEUTICAL DESICCANT MARKET SIZE, BY END USE, 2020-2027 (USD MILLION) 36
FIGURE 16 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY REGION, 2020-2027 (USD MILLION) 39
FIGURE 17 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY TYPE, 2020-2027 (USD MILLION) 40
FIGURE 18 EUROPE: PHARMACEUTICAL DESICCANT MARKET, BY END USE, 2020-2027 (USD MILLION) 41
FIGURE 19 APAC PHARMACEUTICAL DESICCANTS MARKETSHARE, BY COUNTRY, 2020-2027 (USD MILLION) 48
FIGURE 20 APAC PHARMACEUTICAL DESICCANTS MARKET SHARE, BY TYPE, 2020-2027 (USD MILLION) 49
FIGURE 21 ROW PHARMACEUTICAL DESICCANTS MARKET SIZE, BY COUNTRY, 2020-2027 (USD MILLION) 55
FIGURE 22 ROW PHARMACEUTICAL DESICCANTS MARKET SIZE, BY TYPE, 2020-2027 (IN %) 56
FIGURE 23 GROWTH STRATEGIES ADOPTED BY KEY PLAYERS IN GLOBAL PHARMACEUTICAL DESICCANT MARKET, 2020-2027, (IN %) 58
FIGURE 24 NEW PRODUCT DEVELOPMENT: % SHARE BY KEY PLAYERS, 2020-2027, (IN %) 59
FIGURE 25 EXPANSION: % SHARE BY KEY PLAYERS, 2020-2027, (IN %) 59
FIGURE 26 E. I. DU PONT DE NEMOURS AND COMPANY: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 61
FIGURE 27 E. I. DU PONT DE NEMOURS AND COMPANY: GEOGRAPHIC REVENUE MIX, 2020 (IN %) 62
FIGURE 28 E. I. DU PONT DE NEMOURS AND COMPANY: KEY DEVELOPMENTS, 2020-2027 (IN %) 63
FIGURE 29 E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS 63
FIGURE 30 MULTISORB TECHNOLOGIES: KEY DEVELOPMENTS, 2020-2027 (IN %) 65
FIGURE 31 MULTISORB TECHNOLOGIES: SWOT ANALYSIS 65
FIGURE 32 SANNER GMBH: KEY DEVELOPMENTS, 2020-2027 (IN %) 67
FIGURE 33 SANNER GMBH: SWOT ANALYSIS 67
FIGURE 34 CLARIANT GLOBAL: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 68
FIGURE 35 CLARIANT GLOBAL: GEOGRAPHIC REVENUE MIX, 2020 (%) 69
FIGURE 36 CLARIANT GLOBAL: KEY DEVELOPMENTS, 2020-2027 (%) 70
FIGURE 37 CLARIANT GLOBAL: SWOT ANALYSIS 70
FIGURE 38 CSP TECHNOLOGIES, INC: KEY DEVELOPMENTS, 2020-2027 (%) 72
FIGURE 39 CSP TECHNOLOGIES, INC: SWOT ANALYSIS 73
FIGURE 40 W. R. GRACE & CO: TOTAL REVENUE VS SEGMENTAL REVENUE (USD MILLION) 76
FIGURE 41 W. R. GRACE & CO: GEOGRAPHIC REVENUE MIX, 2020 (%) 77
FIGURE 42 W. R. GRACE & CO: KEY DEVELOPMENTS, 2020-2027 (%) 78